Medtrace Pharma A/s

This study tests a new imaging agent called [15-O]-H2O, given through an IV, to see if it can accurately detect coronary artery disease using a PET scan. About 215 adults with suspected heart disease will receive the agent at rest and during stress. The goal is to confirm how wel…